争议事件
以下收录公开来源中与该品牌相关的争议事件。列出一条并不表示过错已经证实。
返回词条共 1 条
2026
Tyenne关节炎注射瓶因玻璃颗粒在全国范围召回
宣布召回
美国食品药品监督管理局警告，400 mg/20 mL的Tyenne（tocilizumab-aazg）注射瓶（批号16UI07）因生产商内部调查发现玻璃颗粒而在全国范围召回。FDA表示，使用被召回药瓶可能导致输注部位局部刺激、疼痛或肿胀、静脉炎症，严重情况下可能阻断血流、导致肺栓塞、永久性器官损伤或死亡。当时尚未报告任何伤害或疾病。
品牌回应
召回 — Tyenne
Injection vials of the prescription arthritis medication Tyenne are being recalled nationwide, according to the U.S. Food & Drug Administration (FDA).
来源摘录
the drug is being recalled after an internal investigation at the manufacturer found glass particles in the affected vials
The recall includes 400 mg/20 mL Tyenne injection vials, which were distributed nationwide to wholesalers, distributors, and direct customers.
Injection vials of the prescription arthritis medication Tyenne are being recalled nationwide, according to the U.S. Food & Drug Administration (FDA).